JPWO2021096270A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021096270A5 JPWO2021096270A5 JP2022528544A JP2022528544A JPWO2021096270A5 JP WO2021096270 A5 JPWO2021096270 A5 JP WO2021096270A5 JP 2022528544 A JP2022528544 A JP 2022528544A JP 2022528544 A JP2022528544 A JP 2022528544A JP WO2021096270 A5 JPWO2021096270 A5 JP WO2021096270A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical compositions
- multiple sclerosis
- treating multiple
- smes
- korea
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 201000006417 multiple sclerosis Diseases 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 102100036009 5'-AMP-activated protein kinase catalytic subunit alpha-2 Human genes 0.000 description 1
- 101000783681 Homo sapiens 5'-AMP-activated protein kinase catalytic subunit alpha-2 Proteins 0.000 description 1
- 230000007987 cellular zinc ion homeostasis Effects 0.000 description 1
- 230000010365 information processing Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000009711 regulatory function Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20190145709 | 2019-11-14 | ||
| KR10-2019-0145709 | 2019-11-14 | ||
| PCT/KR2020/015932 WO2021096270A1 (ko) | 2019-11-14 | 2020-11-12 | Ampk 억제기능과 아연항상성 조절기능에 기반한 다발성 경화증 치료용 약학적 조성물 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023501814A JP2023501814A (ja) | 2023-01-19 |
| JPWO2021096270A5 true JPWO2021096270A5 (enrdf_load_stackoverflow) | 2023-04-25 |
| JP7398840B2 JP7398840B2 (ja) | 2023-12-15 |
Family
ID=75911395
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022528544A Active JP7398840B2 (ja) | 2019-11-14 | 2020-11-12 | Ａｍｐｋ抑制機能と亜鉛恒常性調節機能に基づく多発性硬化症治療用の薬学的組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12343335B2 (enrdf_load_stackoverflow) |
| EP (1) | EP4066832A4 (enrdf_load_stackoverflow) |
| JP (1) | JP7398840B2 (enrdf_load_stackoverflow) |
| KR (1) | KR102770734B1 (enrdf_load_stackoverflow) |
| CN (1) | CN114929217A (enrdf_load_stackoverflow) |
| WO (1) | WO2021096270A1 (enrdf_load_stackoverflow) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4255419A (en) * | 1979-09-27 | 1981-03-10 | Allergan Pharmaceuticals, Inc. | Zinc deficiency in multiple sclerosis |
| AU2003271748A1 (en) | 2002-08-29 | 2004-03-19 | Laboratoires Serono Sa | Protein tyrosine phosphatase inhibitors |
| GB0915892D0 (en) * | 2009-09-10 | 2009-10-14 | Smithkline Beecham Corp | Compounds |
| KR101324647B1 (ko) | 2010-12-10 | 2013-11-01 | 한국과학기술연구원 | 다발성신경경화증의 치료 또는 예방용 조성물 및 이의 스크리닝 방법 |
| ES2650744T3 (es) * | 2010-12-14 | 2018-01-22 | Electrophoretics Limited | Inhibidores de la caseína quinasa 1 delta (CK1delta) |
| EP2685976B1 (en) * | 2011-03-17 | 2017-12-27 | Tel HaShomer Medical Research Infrastructure and Services Ltd. | Quinolone analogs for treating autoimmune diseases |
| CN104059060B (zh) | 2014-05-30 | 2017-08-01 | 西安交通大学 | 一种5‑(1h‑吲哚‑3‑亚甲基)‑1,3‑噻唑烷‑4‑酮类衍生物及其合成方法和应用 |
| KR101911785B1 (ko) | 2016-08-09 | 2018-10-26 | 세종대학교 산학협력단 | Ampk 억제기능에 기반한 뇌졸중 치료용 약학적 조성물 |
-
2020
- 2020-11-12 WO PCT/KR2020/015932 patent/WO2021096270A1/ko not_active Ceased
- 2020-11-12 US US17/776,693 patent/US12343335B2/en active Active
- 2020-11-12 EP EP20887409.9A patent/EP4066832A4/en active Pending
- 2020-11-12 JP JP2022528544A patent/JP7398840B2/ja active Active
- 2020-11-12 KR KR1020227017186A patent/KR102770734B1/ko active Active
- 2020-11-12 CN CN202080093043.2A patent/CN114929217A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SA522431866B1 (ar) | مركبات بروتين-1 المتفاعل من المستقبل تثبيطية وطرق عملها واستخدامها | |
| SA522440778B1 (ar) | Rip1k مثبطات | |
| CN113316574A (zh) | Shp2抑制剂及其应用 | |
| JOP20200278A1 (ar) | مركبات تثبيط rip1 وطرق لتحضير واستخدامها | |
| JOP20210291A1 (ar) | مشتقات حمض إيتاكونيك واستخداماتها في علاج مرض التهابي أو مرض مصاحب لاستجابة مناعية غير مرغوب فيها | |
| PH12020551205A1 (en) | Fap inhibitors | |
| BR112018072542A2 (pt) | derivados de piridiniltriazol substituído com amida e usos dos mesmos | |
| CN111683928A (zh) | 作为fgfr抑制剂的吡嗪-2(1h)-酮类化合物 | |
| MX2021007069A (es) | 3,3-difluoroalilaminas o sales de las mismas y composiciones farmaceuticas que comprenden las mismas. | |
| BR112021023054A2 (pt) | Formas cristalinas de um inibidor de btk | |
| CN110869369A (zh) | 五元并六元氮杂芳环类化合物、其制备方法、药用组合物及其应用 | |
| JP2017155062A5 (enrdf_load_stackoverflow) | ||
| CN114846009A (zh) | 具有khk抑制作用的化合物 | |
| EA202192925A1 (ru) | Твердые формы ингибитора glyt1 | |
| CN111295380A (zh) | 一种高活性csf1r抑制剂化合物 | |
| CN113825755A (zh) | 作为irak4抑制剂的咪唑并吡啶类化合物 | |
| JPWO2021096270A5 (enrdf_load_stackoverflow) | ||
| WO2018231058A3 (en) | ANTIMICROBIAL PEPTIDES AND THEIR MIXTURES HAVING ANTIMICROBIAL ACTIVITY AGAINST NEGATIVE GRAM PATHOGENS | |
| WO2018143666A3 (ko) | Cap1로부터 유래된 폴리펩티드 및 이를 유효성분으로 포함하는 약학적 조성물 | |
| WO2020060779A3 (en) | Methods and compositions for treating laminopathies affecting skeletal or cardiac muscle | |
| MX2025003831A (es) | Compuesto de anillo fusionado y agente farmacéutico que contiene el mismo. | |
| CN110177774A (zh) | 作为Caspase抑制剂的联环化合物 | |
| WO2019155360A3 (en) | Pharmaceutical composition for treating bacterial and viral infections | |
| MX2021006138A (es) | Otros compuestos heteroaromaticos que tienen actividad contra el vrs. | |
| CN111615515A (zh) | 杂环化合物、制备方法及其在医药上的应用 |